ABSTRACT Background Folate receptor‐⍺ (FR‐⍺) is an attractive target for targeted therapy. Mirvetuximab soravtansine (MIRV) has been approved by the United States Food and Drug Administration (FDA) for treating adult patients with FR‐⍺ positive, platinum‐resistant epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Therefore,
Yadan Ma +5 more
wiley +1 more source
Fallopian tube origin of supposed ovarian high-grade serous carcinomas
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal cancers, and can also be detected in the endometrium and fallopian tubes.
Patricia Martini Diniz +3 more
doaj
Comparison of Immediate and Delayed Transfer of Micro- Injected Oocytes into Fallopian Tubes: A Prospective, Randomized Clinical Trial [PDF]
Background Transfer of micro-Injected oocytes into fallopian tubes is an alternative procedure for IVF-ET with a similar success rate. This could be either done immediately after ovum pick-up microinjected oocytes intrafallopian transfer (MIFT) or after ...
Ashraf Alleyassin +4 more
doaj +1 more source
Torsion of fallopian tube, fimbrial cyst [PDF]
A case of fallopian tube fimbrial cyst torsion with haemorrhage is presented, occurring in a 37-year-old female who had tubal ligation 6 years back. She presented in emergency with acute abdomen.
Khan, Nadir, Masroor, Imrana
core +1 more source
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja +11 more
wiley +1 more source
Histomorphology of fallopian tubes in ectopic pregnancy
Background: Ectopic pregnancy can present as an acute life-threatening emergency when it ruptures and accounts for about 10% of all maternal mortalities. The fallopian tube is the most common site for ectopic pregnancy (90–95%).
Savithri Ravindra +2 more
doaj +1 more source
Inflammation targets specific organs for cancer in carriers of BRCA1/2 pathway mutations [PDF]
Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast/ovarian cancer that are so high and apparently so selective that many mutation carriers choose to have the most likely targets for cancer surgically removed.
Bernard Friedenson
core +1 more source
Ovarian Endometrioid Adenocarcinomas With Infiltrative “Adenofibroma-like” Morphology and Aberrant ß-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube [PDF]
Jin Xu +3 more
openalex +1 more source
What's New? The DNA methylation‐based WID‐qEC test has been validated for the accurate detection of endometrial and cervical cancers using cervico‐vaginal samples. However, a small proportion of women test positive despite the absence of these cancers. This study explored the associated biological and clinical characteristics to inform potential follow‐
Elisa Redl +18 more
wiley +1 more source
Persistent mullerian duct syndrome
Persistent Mullerian duct syndrome (PMDS) is a rare form of internal male pseudohermaphroditism in which Mullerian duct derivatives are seen in a male patient. This syndrome is characterized by the persistence of Mullerian duct derivatives (i.e.
Divya Renu, B Ganesh Rao, K Ranganath
doaj +3 more sources

